These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15603440)

  • 1. T-cell responses to cancer.
    Lee PP
    Methods Cell Biol; 2004; 75():513-32. PubMed ID: 15603440
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometry applications of MHC tetramers.
    Altman JD
    Methods Cell Biol; 2004; 75():433-52. PubMed ID: 15603436
    [No Abstract]   [Full Text] [Related]  

  • 3. Multicolor immunophenotyping: human mature immune system.
    De Rosa SC
    Methods Cell Biol; 2004; 75():577-94. PubMed ID: 15603443
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicolor flow cytometric analysis in SIV-infected rhesus macaque.
    Walker JM; Maecker HT; Maino VC; Picker LJ
    Methods Cell Biol; 2004; 75():535-57. PubMed ID: 15603441
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo tracking of tumor-specific T cells.
    Yee C; Riddell SR; Greenberg PD
    Curr Opin Immunol; 2001 Apr; 13(2):141-6. PubMed ID: 11228405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of T-cell degranulation: CD107a and b.
    Betts MR; Koup RA
    Methods Cell Biol; 2004; 75():497-512. PubMed ID: 15603439
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing antigen-specific proliferation and cytokine responses using flow cytometry.
    Allsopp CE; Langhorne J
    Methods Mol Med; 2002; 72():409-21. PubMed ID: 12125136
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes.
    Labarriere N; Pandolfino MC; Raingeard D; Le Guiner S; Diez E; Le Dréan E; Dreno B; Jotereau F
    Int J Cancer; 1998 Oct; 78(2):209-15. PubMed ID: 9754654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Intracellular Cytokines by Flow Cytometry.
    Yin Y; Mitson-Salazar A; Prussin C
    Curr Protoc Immunol; 2015 Aug; 110():6.24.1-6.24.18. PubMed ID: 26237012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
    Avril T; Saikali S; Vauleon E; Jary A; Hamlat A; De Tayrac M; Mosser J; Quillien V
    J Neuroimmunol; 2010 Aug; 225(1-2):22-33. PubMed ID: 20493562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated.
    Reyes E; Carballido J; Prieto A; Molto L; Manzano L; Alvarez-Mon M
    Eur Urol; 1997; 31(4):472-7. PubMed ID: 9187910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human autologous melanoma-specific cytotoxic T cells from tumor-involved lymph nodes.
    Maeda K; Lafreniere R; McKinnon JG; Jerry LM
    Mol Biother; 1991 Jun; 3(2):95-102. PubMed ID: 1910625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OMIP-023: 10-color, 13 antibody panel for in-depth phenotyping of human peripheral blood leukocytes.
    Bocsi J; Melzer S; Dähnert I; Tárnok A
    Cytometry A; 2014 Sep; 85(9):781-4. PubMed ID: 25132115
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments in flow cytometry.
    Scheffold A; Kern F
    J Clin Immunol; 2000 Nov; 20(6):400-7. PubMed ID: 11202229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for immunophenotyping and purifying classical Hodgkin lymphoma cells from lymph nodes by flow cytometry and flow cytometric cell sorting.
    Fromm JR; Wood BL
    Methods; 2012 Jul; 57(3):368-75. PubMed ID: 22487184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE class.
    Brischwein K; Parr L; Pflanz S; Volkland J; Lumsden J; Klinger M; Locher M; Hammond SA; Kiener P; Kufer P; Schlereth B; Baeuerle PA
    J Immunother; 2007; 30(8):798-807. PubMed ID: 18049331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry.
    Devêvre E; Romero P; Mahnke YD
    J Immunol Methods; 2006 Apr; 311(1-2):31-46. PubMed ID: 16527300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients.
    Janssen N; Fortis SP; Speigl L; Haritos C; Sotiriadou NN; Sofopoulos M; Arnogiannaki N; Stavropoulos-Giokas C; Dinou A; Perez S; Pawelec G; Baxevanis CN; Shipp C
    Breast Cancer Res Treat; 2017 Jan; 161(1):51-62. PubMed ID: 27787640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in CD8+ lymphocytes in atopic dermatitis is associated with a preferential loss of cytotoxic effector cells rather than suppressor inducer cells.
    McCoy JP; Hanley-Yanez K; Tharp MD
    Ann N Y Acad Sci; 1993 Mar; 677():422-4. PubMed ID: 8494231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.